perora GmbH, a Heidelberg, Germany-based biotech company, raised a seed funding round of undisclosed amount.
The backer was High-Tech-Gründerfonds.
Incorporated in June 2013 and led by Dr. Dirk Vetter, Managing Director, and Dr. Kristina Schmidt, Chief Admin and Operations Officer, perora develops a polymer-based fat-binding medical device as a novel platform for weight management and the treatment of obesity.
The company intends to use the funds to develop its s lead program, a medical device for the treatment of obesity and diabetes type II.
FinSMEs
16/09/2013